Retour
Fourchette du Jour
7,61 €
8,18 €
Fourchette 52 Semaines
6,66 €
18,90 €
Volume
1 869 456
Moyenne 50J / 200J
9,69 €
/
11,76 €
Clôture Précédente
7,54 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,6 | 0,2 |
| P/B | 6,9 | 3,0 |
| ROE % | -92,3 | 3,5 |
| Net Margin % | -203,3 | 3,8 |
| Rev Growth 5Y % | 97,8 | 9,7 |
| D/E | 0,9 | 0,2 |
Objectif de Cours des Analystes
Hold
29,33 €
+271.3%
Low: 26,00 €
High: 32,00 €
BPA Prévisionnel
-1,47 €
CA Est.
160,28M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,72 €
1,14 € – 2,07 €
|
689,76M | 1 |
| FY2029 |
1,11 €
0,74 € – 1,34 €
|
582,22M | 1 |
| FY2028 |
0,20 €
-0,92 € – 0,82 €
|
427,81M | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-09 | -0,43 € | -0,42 € | +2,3% |
| 2025-11-10 | -0,45 € | -0,52 € | -15,6% |
| 2025-08-13 | -0,41 € | -0,46 € | -12,2% |
| 2025-05-14 | -0,35 € | -0,35 € | 0,0% |
| 2025-03-20 | -0,04 € | 0,52 € | +1400,0% |
| 2024-11-13 | -0,18 € | -0,20 € | -11,1% |
| 2024-08-06 | -0,12 € | -0,13 € | -8,3% |
| 2024-05-09 | -0,11 € | -0,11 € | 0,0% |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 |
Dorsey Brian
Chief Operating Officer
|
grant | 240 000 | — | — |
| Jan 2, 2026 |
Chakma Justin
Chief Business Officer
|
grant | 240 000 | — | — |
| Jan 2, 2026 |
Scott Kathleen D.
Chief Financial Officer
|
grant | 240 000 | — | — |
| Jan 2, 2026 |
Lowenthal Richard E
PRESIDENT AND CEO
|
grant | 1 115 000 | — | — |
| Jan 2, 2026 |
Tanimoto Sarina
CHIEF MEDICAL OFFICER
|
grant | 1 115 000 | — | — |
| Nov 13, 2025 |
Dorsey Brian
Chief Operating Officer
|
other | 43 656 | 0,64 € | — |
| Nov 13, 2025 |
Dorsey Brian
Chief Operating Officer
|
sell | 21 828 | 8,71 € | 190 049,85 € |
| Aug 21, 2025 |
Scott Kathleen D.
Chief Financial Officer
|
other | 25 000 | 1,50 € | — |
| Aug 21, 2025 |
Scott Kathleen D.
Chief Financial Officer
|
sell | 12 500 | 15,00 € | 187 500,00 € |
| Jul 1, 2025 |
Karas Eric
Chief Commercial Officer
|
other | 30 000 | 1,50 € | — |
| Jul 1, 2025 |
Karas Eric
Chief Commercial Officer
|
sell | 15 000 | 16,99 € | 254 860,50 € |
| Jun 25, 2025 |
Shawver Laura
|
grant | 30 000 | — | — |
| Jun 25, 2025 |
Islam Saqib
|
grant | 30 000 | — | — |
| Jun 25, 2025 |
Shah Pratik
|
grant | 30 000 | — | — |
| Jun 25, 2025 |
Dadoo Rajeev
|
grant | 30 000 | — | — |
| Jun 25, 2025 |
Kelly Michael
|
grant | 30 000 | — | — |
| Jun 25, 2025 |
SAUNDERS BRENT L
|
grant | 30 000 | — | — |
| Jun 18, 2025 |
Karas Eric
Chief Commercial Officer
|
other | 30 000 | 1,50 € | — |
| Jun 18, 2025 |
Karas Eric
Chief Commercial Officer
|
sell | 15 000 | 16,00 € | 240 000,00 € |
| May 20, 2025 |
SAUNDERS BRENT L
|
other | 240 000 | 1,01 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 97,80% annually over 5 years — strong growth
Earnings declined -2241,76% over the past year
Negative free cash flow of -171,21M
PEG of 0,00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 103,26%
Capital efficient — spends only 0,40% of revenue on capex
Croissance
Revenue Growth (5Y)
97,80%
Revenue (1Y)-5,46%
Earnings (1Y)-2241,76%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-92,33%
ROIC-63,72%
Net Margin-203,25%
Op. Margin-212,92%
Sécurité
Debt / Equity
0,85
Current Ratio7,28
Interest Coverage-69,05
Valorisation
P/E Ratio
-4,58
Forward P/EN/A
P/B Ratio6,87
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5,46% | Revenue Growth (3Y) | 5200,25% |
| Earnings Growth (1Y) | -2241,76% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 97,80% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 84,28M | Net Income (TTM) | -171,30M |
| ROE | -92,33% | ROA | -52,28% |
| Gross Margin | 75,77% | Operating Margin | -212,92% |
| Net Margin | -203,25% | Free Cash Flow (TTM) | -171,21M |
| ROIC | -63,72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,85 | Current Ratio | 7,28 |
| Interest Coverage | -69,05 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4,58 | Forward P/E | N/A |
| P/B Ratio | 6,87 | P/S Ratio | 9,31 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 4,89 | Fwd Earnings Yield | N/A |
| FCF Yield | -21,82% | ||
| Market Cap | 784,45M | Enterprise Value | 840,09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 84,28M | 89,15M | 30 000,0 | 1,32M | 5,51M |
| Net Income | -171,30M | 8,00M | -54,37M | -34,68M | -20,24M |
| EPS (Diluted) | -1,74 | 0,08 | -0,57 | -0,87 | -0,70 |
| Gross Profit | 63,86M | 68,59M | 30 000,0 | 1,32M | 5,29M |
| Operating Income | -179,45M | -3,08M | -67,52M | -35,52M | -19,45M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 327,65M | 351,15M | 233,19M | 281,44M | 61,45M |
| Total Liabilities | 213,39M | 94,36M | 2,43M | 8,55M | 92,72M |
| Shareholders' Equity | 114,26M | 256,80M | 230,76M | 272,89M | -31,27M |
| Total Debt | 96,96M | 42 000,0 | 274 000,0 | 481 000,0 | 9,03M |
| Cash & Equivalents | 41,32M | 50,82M | 70,97M | 210,52M | 60,06M |
| Current Assets | 284,90M | 334,30M | 231,56M | 277,70M | 60,73M |
| Current Liabilities | 39,15M | 23,44M | 2,39M | 5,44M | 8,19M |